<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">180</article-id>
<title-group><article-title>Is Covid-19 severe in patients with Alzheimer&apos;s disease?</article-title></title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Mirzaei</surname><given-names>Mohaddeseh</given-names></name></contrib>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><month>04</month><year>2023</year></pub-date>
<volume>4</volume>
<issue>2</issue>
<fpage>53</fpage>
<lpage>56</lpage>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/180/is-covid-19-severe-in-patients-with-alzheimer-s-disease"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/180/download"/>
<abstract><p>Alzheimer&apos;s disease (AD), as a degenerative neurodegenerative disease that has a growing trend causes the exacerbation of the infectious disease of COVID-19, or on the contrary, the infection of Covid-19 can aggravate the symptoms of AD and the severe form of COVID-19 appears. There are several mechanisms for the worsening of AD condition after COVID-19. It is reasonable to assume that COVID-19 has a more severe impact on patients with comorbidities, including those with AD. As such, individuals with AD should take additional preventive measures to avoid contracting COVID-19, as they are at a heightened risk of developing severe symptoms of the disease, which could result in increased mortality rates.


 </p></abstract>
</article-meta>
</front>
</article>